Literature DB >> 26854929

T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.

Scott J Patterson, Anne M Pesenacker, Adele Y Wang, Jana Gillies, Majid Mojibian, Kim Morishita, Rusung Tan, Timothy J Kieffer, C Bruce Verchere, Constadina Panagiotopoulos, Megan K Levings.   

Abstract

T regulatory cells (Tregs) control immune homeostasis by preventing inappropriate responses to self and nonharmful foreign antigens. Tregs use multiple mechanisms to control immune responses, all of which require these cells to be near their targets of suppression; however, it is not known how Treg-to-target proximity is controlled. Here, we found that Tregs attract CD4+ and CD8+ T cells by producing chemokines. Specifically, Tregs produced both CCL3 and CCL4 in response to stimulation, and production of these chemokines was critical for migration of target T cells, as Tregs from Ccl3-/- mice, which are also deficient for CCL4 production, did not promote migration. Moreover, CCR5 expression by target T cells was required for migration of these cells to supernatants conditioned by Tregs. Tregs deficient for expression of CCL3 and CCL4 were impaired in their ability to suppress experimental autoimmune encephalomyelitis or islet allograft rejection in murine models. Moreover, Tregs from subjects with established type 1 diabetes were impaired in their ability to produce CCL3 and CCL4. Together, these results demonstrate a previously unappreciated facet of Treg function and suggest that chemokine secretion by Tregs is a fundamental aspect of their therapeutic effect in autoimmunity and transplantation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26854929      PMCID: PMC4767359          DOI: 10.1172/JCI83987

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.

Authors:  Angela M Thornton; Erin E Donovan; Ciriaco A Piccirillo; Ethan M Shevach
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

2.  Homing to suppress: address codes for Treg migration.

Authors:  Jochen Huehn; Alf Hamann
Journal:  Trends Immunol       Date:  2005-10-21       Impact factor: 16.687

Review 3.  Chemokines and their receptors: drug targets in immunity and inflammation.

Authors:  Antonella Viola; Andrew D Luster
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Long-range disruption of gene expression by a selectable marker cassette.

Authors:  C T Pham; D M MacIvor; B A Hug; J W Heusel; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB.

Authors:  R Rezzonico; V Imbert; R Chicheportiche; J M Dayer
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  Requirement of MIP-1 alpha for an inflammatory response to viral infection.

Authors:  D N Cook; M A Beck; T M Coffman; S L Kirby; J F Sheridan; I B Pragnell; O Smithies
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

8.  Immune homeostasis enforced by co-localized effector and regulatory T cells.

Authors:  Zhiduo Liu; Michael Y Gerner; Nicholas Van Panhuys; Andrew G Levine; Alexander Y Rudensky; Ronald N Germain
Journal:  Nature       Date:  2015-11-25       Impact factor: 49.962

9.  Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.

Authors:  Adam P Kohm; Pamela A Carpentier; Holly A Anger; Stephen D Miller
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

10.  Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

Authors:  Joerg Ermann; Petra Hoffmann; Matthias Edinger; Suparna Dutt; Francis G Blankenberg; John P Higgins; Robert S Negrin; C Garrison Fathman; Samuel Strober
Journal:  Blood       Date:  2004-11-16       Impact factor: 22.113

View more
  22 in total

1.  Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Authors:  Jeongsu Do; Dongkyun Kim; Sohee Kim; Alice Valentin-Torres; Nina Dvorina; Eunjung Jang; Vivekananthan Nagarajavel; Tara M DeSilva; Xiaoxia Li; Angela H Ting; Dario A A Vignali; Stephen A Stohlman; William M Baldwin; Booki Min
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

2.  Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates.

Authors:  Davide Simone; Frank Penkava; Anna Ridley; Stephen Sansom; M Hussein Al-Mossawi; Paul Bowness
Journal:  Commun Biol       Date:  2021-12-14

3.  Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.

Authors:  Joseph R Podojil; Samantha Genardi; Ming-Yi Chiang; Sandeep Kakade; Tobias Neef; Tushar Murthy; Michael T Boyne; Adam Elhofy; Stephen D Miller
Journal:  J Immunol       Date:  2022-06-20       Impact factor: 5.426

4.  Distinct Injury Responsive Regulatory T Cells Identified by Multi-Dimensional Phenotyping.

Authors:  Fei Guo; Brandon Hancock; Alec Griffith; Hui Lin; Kaitlyn Howard; Joshua Keegan; Fan Zhang; Adam Chicoine; Laura Cahill; Julie Ng; James Lederer
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

5.  Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.

Authors:  H Ryan Kolb; Nicholas Borcherding; Weizhou Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 6.  Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

Authors:  Ting-Ting Chang; Jaw-Wen Chen
Journal:  Cardiovasc Diabetol       Date:  2016-08-24       Impact factor: 9.951

7.  Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis.

Authors:  Asma Ahmed; Vasista Adiga; Soumya Nayak; J Anto Jesuraj Uday Kumar; Chirag Dhar; Pravat Nalini Sahoo; Bharath K Sundararaj; George D Souza; Annapurna Vyakarnam
Journal:  PLoS Pathog       Date:  2018-09-19       Impact factor: 6.823

Review 8.  Identifying the 'Achilles heel' of type 1 diabetes.

Authors:  M Battaglia; J H Buckner; M K Levings; S J Richardson; F S Wong; T I Tree
Journal:  Clin Exp Immunol       Date:  2021-02-22       Impact factor: 4.330

9.  Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.

Authors:  Carlos R Figueiredo; Helen Kalirai; Joseph J Sacco; Ricardo A Azevedo; Andrew Duckworth; Joseph R Slupsky; Judy M Coulson; Sarah E Coupland
Journal:  J Pathol       Date:  2020-04       Impact factor: 7.996

10.  CCL3 Promotes Germinal Center B Cells Sampling by Follicular Regulatory T Cells in Murine Lymph Nodes.

Authors:  Zachary L Benet; Matangi Marthi; Fang Ke; Rita Wu; Jackson S Turner; Jahan B Gabayre; Michael I Ivanitskiy; Sahil S Sethi; Irina L Grigorova
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.